Israel vs Slovakia: 10_Insured export credit exposures, short term (BU)
Israel
10.65 billion BU
in 2025
Slovakia
9.82 billion BU
in 2025
Israel rank
45th
Slovakia rank
47th
10_Insured export credit exposures, short term (BU) over time
- Israel
- Slovakia
How they compare
Israel currently reports 10.65 billion BU against 9.82 billion BU in Slovakia, a difference of 823.00 million BU.
That makes Israel's figure about 1.1 times Slovakia's.
Across all 21 years both countries report, Israel has been ahead every year.
Israel ranks 45th and Slovakia ranks 47th of 212 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.89 billion BU | 2.84 billion BU | 1.05 billion BU | Israel |
| 2010s | 5.62 billion BU | 4.74 billion BU | 885.90 million BU | Israel |
| 2020s | 10.59 billion BU | 8.98 billion BU | 1.61 billion BU | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Israel or Slovakia?
- Israel, at 10.65 billion BU against 9.82 billion BU in Slovakia as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Israel and Slovakia?
- 823.00 million BU, with Israel ahead.
- How many years of comparable data are there for Israel and Slovakia?
- 21 years are reported by both, from 2005 to 2025.
- How do Israel and Slovakia rank globally for 10_insured export credit exposures, short term?
- Israel ranks 45th and Slovakia ranks 47th of 212 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).